Effect of charred Radix et Rhizoma Rhei in a laser-induced choroidal neovascularization murine model

被引:8
|
作者
Han, Dongmei [1 ]
Yao, Yuan [1 ]
Sun, Yong [1 ]
Gong, Yuanyuan [1 ]
Wu, Xingwei [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai 200080, Peoples R China
关键词
charred Radix et Rhizoma Rhei; choroidal neovascularization; traditional Chinese medicine; age-associated macular degeneration; interleukin-10; MACULAR DEGENERATION; ANGELICA-SINENSIS; INTRAVITREAL TRIAMCINOLONE; ANTIINFLAMMATORY ACTIVITY; PHOTODYNAMIC THERAPY; PANAX-NOTOGINSENG; PORIA-COCOS; IN-VITRO; EXTRACT; EXPRESSION;
D O I
10.3892/mmr.2014.3046
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A pharmaceutical composition (patent no. WO2012079419) exhibited favorable outcomes in a clinical trial of wet age-related macular degeneration. The aims of the present study were to explore the effects of one composition component, charred Radix et Rhizoma Rhei (CRRR), in a laser-induced choroidal neovascularization (CNV) murine model. A total of 30 eight-week-old C57BL/6 mice were subjected to diode laser treatment, and CNV was induced by rupturing the Bruch's membrane. The mice were then randomly divided into two groups: the CRRR-treated group that was administered CRRR water extract (concentration, 0.6 g/100 ml; dose, 1 ml/0.1 kg twice a day for 21 days); and the control group that was treated with saline (dose, 1 ml/0.1 kg twice a day for 21 days). The retinal tissue was subjected to quantitative polymerase chain reaction (qPCR) and western blot analysis to determine the expression levels of interleukin-10 (IL-10) and vascular epithelial growth factor (VEGF) at day seven following laser treatment. At weeks 2 and 3 after laser treatment, fundus fluorescein angiography was performed and graded to assess the severity of lesion leakage. Retinal flat mounts were prepared for three-dimensional confocal microscopy at day 22 after laser treatment. At days 14 and 21 after laser treatment, no statistically significant differences were observed between the clinically relevant lesions of the CRRR-treated and control mice. CNV volumes were not found to be significantly different between the CRRR-treated and control mice. The expression levels of IL-10 were significantly increased in the CRRR-treated mice (P<0.05). However, no statistically significant differences were observed between the VEGF expression levels of the CRRR-treated and control mice. In conclusion, CRRR did not appear to significantly inhibit CNV in this murine model. The function of CRRR in the pharmaceutical composition may be due to the effects of IL-10 and a synergistic effect with other components of the composition. However, further investigation is required.
引用
收藏
页码:2896 / 2902
页数:7
相关论文
共 50 条
  • [21] Suppression of laser-induced choroidal neovascularization by intravitreal injection of tristetraprolin
    Cho, Yong Wail
    Han, Yong Seop
    Chung, In Young
    Kim, Seong Jae
    Wook-Seo, Seong
    Yoo, Ji Myong
    Park, Jong Moon
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2014, 7 (06) : 952 - 958
  • [22] Blockage of tissue factor ameliorates the lesion of laser-induced choroidal neovascularization in mice
    Wang, Li
    Yang, Zhongkai
    Yu, Ying
    Cui, Chen
    Guan, Huaijin
    Chen, Hui
    EXPERIMENTAL EYE RESEARCH, 2014, 127 : 117 - 123
  • [23] Intravitreal itraconazole inhibits laser-induced choroidal neovascularization in rats
    Bae, Jeong Hun
    Hwang, Ah Reum
    Kim, Chan Yun
    Yu, Hyeong Gon
    Koh, Hyoung Jun
    Yang, Woo Ick
    Chang, Hae Ran
    Lee, Sung Chul
    PLOS ONE, 2017, 12 (06):
  • [24] Dynamic changes in macrophage morphology during the progression of choroidal neovascularization in a laser-induced choroidal neovascularization mouse model
    Nana Xu
    Tao Sun
    Yulan Wang
    Xiaowei Tong
    Shiheng Lu
    Fan Yang
    Jing Wang
    Qiyu Bo
    Junran Sun
    Xiaodong Sun
    BMC Ophthalmology, 23
  • [25] Anti-sphingosine-1-phosphate monoclonal antibodies inhibit angiogenesis and sub-retinal fibrosis in a murine model of laser-induced choroidal neovascularization
    Caballero, Sergio
    Swaney, James
    Moreno, Kelli
    Afzal, Aqeela
    Kielczewski, Jennifer
    Stoller, Glenn
    Cavalli, Amy
    Garland, William
    Hansen, Genevieve
    Sabbadini, Roger
    Grant, Maria B.
    EXPERIMENTAL EYE RESEARCH, 2009, 88 (03) : 367 - 377
  • [26] Suppression of Laser-Induced Choroidal Neovascularization by Nontargeted siRNA
    Ashikari, Masayuki
    Tokoro, Mayumi
    Itaya, Masahiro
    Nozaki, Miho
    Ogura, Yuichiro
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (07) : 3820 - 3824
  • [27] Laser-Induced Choroidal Neovascularization in Mice Attenuated by Deficiency in the Apelin-APJ System
    Hara, Chikako
    Kasai, Atsushi
    Gomi, Fumi
    Satooka, Tatsuya
    Sakimoto, Susumu
    Nakai, Kei
    Yoshioka, Yasuhiro
    Yamamuro, Akiko
    Maeda, Sadaaki
    Nishida, Kohji
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (06) : 4321 - 4329
  • [28] Delayed regression of laser-induced choroidal neovascularization in TNFα-null mice
    Iwanishi, Hiroki
    Yamanaka, Osamu
    Sumioka, Takayoshi
    Yasuda, Shingo
    Miyajima, Masayasu
    Saika, Shizuya
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2022, 26 (20) : 5315 - 5325
  • [29] Dendritic cells play no significant role in the laser-induced choroidal neovascularization model
    Droho, Steven
    Perlman, Harris
    Lavine, Jeremy A.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [30] Repeated retinal photocoagulation in monkeys for the optimization of a laser-induced choroidal neovascularization model
    Lin, Xingyan
    Wang, Qilin
    He, Mingguang
    EXPERIMENTAL EYE RESEARCH, 2019, 184 : 1 - 7